Tech Company Financing Transactions
Cancer Genetics Funding Round
Cancer Genetics closed a $5.5 million financing round on 12/7/2016. Investors included private investors.
Transaction Overview
Company Name
Announced On
12/7/2016
Transaction Type
Venture Equity
Amount
$5,500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 16 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
201 Route 17 North 2nd Floor
Rutherford, NJ 07070
USA
Rutherford, NJ 07070
USA
Phone
Website
Email Address
Overview
Cancer Genetics, Inc. develops, commercializes, and provides molecular and biomarker-based tests and services in the United States, India, and China.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Roberts
Chief Financial Officer
Glenn Miles
Executive Vice President
William Finger
President
Ralf Brandt
VP - Bus. Development
Michael McCartney
Browse more venture capital transactions:
Prev: 12/7/2016: Unearth venture capital transaction
Next: 12/7/2016: RapidSOS venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs